Uncategorized | EPIC Emerging & Pandemic Infections Consortium

The Canada-Africa Mpox Partnership launches with $3 million team grant

Dec 21, 2022 | Uncategorized

Researchers from the University of Toronto and Nigerian Institute of Medical Research have received $3 million from the federal government to launch an international project that will help inform the clinical and public health response to local and global epidemic of mpox. The new funding from the Canadian Institutes of Health Research (CIHR) and International Development Research Centre builds on the collaborative projects and seed funding from the mpox rapid research response launched by EPIC earlier this year.

World AIDS Day: Meet the next generation of HIV/AIDS researchers

Dec 1, 2022 | Uncategorized

On World AIDS Day, we spotlight eight talented trainees who are doing impactful work on HIV/AIDS.

World Antimicrobial Awareness Week: How U of T researchers are tackling the global challenge of antimicrobial resistance

Nov 21, 2022 | Uncategorized

As the global health and research communities mark World Antimicrobial Awareness Week, members of the Emerging and Pandemic Infections Consortium (EPIC) are making strides in the fight against antimicrobial resistance. L

EPIC announces new 12-person steering committee

Oct 24, 2022 | Uncategorized

The Emerging and Pandemic Infections Consortium (EPIC) is pleased to introduce its inaugural steering committee. Meet the 12 members of our steering committee!

Science Literacy Week 2022: Meet two mathematical modellers!

Sep 21, 2022 | Uncategorized

September 19 to 25 marks Science Literacy Week in Canada, an opportunity to showcase how science, discovery and ingenuity shape our lives. The theme for Science Literacy Week 2022 is mathematics so we decided to sit down with two young scientists to talk about mathematical modelling of infectious diseases and their own personal work in that area.

U of T partners with Moderna to advance research in RNA science and technology

Apr 29, 2022 | Uncategorized

By Rahul Kalvapalle The University of Toronto and Moderna, Inc. – known for its mRNA-based COVID-19 vaccine – plan to work together to develop new tools to prevent and treat infectious diseases. Guided by a partnership framework agreement, the U.S. biotechnology firm...

In the next pandemic, Canada will be prepared

Nov 18, 2021 | Uncategorized

The Toronto High Containment Facility (THCF), housed at the University of Toronto’s Temerty Faculty of Medicine, is equipped to safely study pathogens that cause infectious disease, and was among the first labs in Canada to enable researchers to work with SaRS-CoV-2 samples.

While similar facilities elsewhere had closed after the 2003 SARS outbreak, the U of T lab remained open – supporting a vast research community including academic, hospital and industrial research needs – and was able to make a significant contribution to understanding and addressing the COVID-19 pandemic.

Canada Foundation for Innovation support advances collaboration among U of T, SickKids and UHN researchers

Nov 14, 2021 | Uncategorized

Originally published on the University of Toronto Rahul Kalvapalle Two projects involving researchers at the University of Toronto and its partner hospitals, each aimed at better understanding and tackling COVID-19, have been awarded a combined total of nearly $2.5...

Revitalizing the life sciences ecosystem in Canada critical to country’s health security

Nov 10, 2021 | Uncategorized

The University of Toronto is bringing together researchers, pharmaceutical innovators and government partners to address gaps in Canada’s biomanufacturing ecosystem and discuss solutions for public health challenges such as COVID-19.

AI deployed in search for antiviral drugs

Nov 4, 2021 | Uncategorized

Originally published on University of Toronto By Paul Fraumeni In an age of COVID-19, the phrase “business as usual” has nearly lost all meaning for Canadians who have seen their lives disrupted in myriad ways. That includes researchers Jean-Philippe...

The Canada-Africa Mpox Partnership launches with $3 million team grant

World AIDS Day: Meet the next generation of HIV/AIDS researchers

World Antimicrobial Awareness Week: How U of T researchers are tackling the global challenge of antimicrobial resistance

EPIC announces new 12-person steering committee

Science Literacy Week 2022: Meet two mathematical modellers!

U of T partners with Moderna to advance research in RNA science and technology

In the next pandemic, Canada will be prepared

Canada Foundation for Innovation support advances collaboration among U of T, SickKids and UHN researchers

Revitalizing the life sciences ecosystem in Canada critical to country’s health security

AI deployed in search for antiviral drugs

Categories

Related links

EPIC is a partnership.